Literature DB >> 24911463

Strategies for immortalization of primary hepatocytes.

Eva Ramboer1, Bram De Craene2, Joery De Kock3, Tamara Vanhaecke3, Geert Berx2, Vera Rogiers3, Mathieu Vinken3.   

Abstract

The liver has the unique capacity to regenerate in response to a damaging event. Liver regeneration is hereby largely driven by hepatocyte proliferation, which in turn relies on cell cycling. The hepatocyte cell cycle is a complex process that is tightly regulated by several well-established mechanisms. In vitro, isolated hepatocytes do not longer retain this proliferative capacity. However, in vitro cell growth can be boosted by immortalization of hepatocytes. Well-defined immortalization genes can be artificially overexpressed in hepatocytes or the cells can be conditionally immortalized leading to controlled cell proliferation. This paper discusses the current immortalization techniques and provides a state-of-the-art overview of the actually available immortalized hepatocyte-derived cell lines and their applications.
Copyright © 2014 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Hepatocyte; Immortalization; Proliferation; Senescence

Mesh:

Year:  2014        PMID: 24911463      PMCID: PMC4169710          DOI: 10.1016/j.jhep.2014.05.046

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  171 in total

1.  The HepaRG cell line: biological properties and relevance as a tool for cell biology, drug metabolism, and virology studies.

Authors:  Marie-Jeanne Marion; Olivier Hantz; David Durantel
Journal:  Methods Mol Biol       Date:  2010

2.  Transplantation of conditionally immortalized hepatocytes to treat hepatic encephalopathy.

Authors:  I K Schumacher; T Okamoto; B H Kim; N R Chowdhury; J R Chowdhury; I J Fox
Journal:  Hepatology       Date:  1996-08       Impact factor: 17.425

3.  Phosphorylation of cyclin D1 at Thr 286 during S phase leads to its proteasomal degradation and allows efficient DNA synthesis.

Authors:  Yang Guo; Ke Yang; Jyoti Harwalkar; Jeffrey M Nye; David R Mason; Michelle D Garrett; Masahiro Hitomi; Dennis W Stacey
Journal:  Oncogene       Date:  2005-04-14       Impact factor: 9.867

Review 4.  Human artificial chromosomes for gene delivery and the development of animal models.

Authors:  Yasuhiro Kazuki; Mitsuo Oshimura
Journal:  Mol Ther       Date:  2011-07-12       Impact factor: 11.454

5.  SV40 T antigen alone drives karyotype instability that precedes neoplastic transformation of human diploid fibroblasts.

Authors:  F A Ray; D S Peabody; J L Cooper; L S Cram; P M Kraemer
Journal:  J Cell Biochem       Date:  1990-01       Impact factor: 4.429

Review 6.  Recent developments on human cell lines for the bioartificial liver.

Authors:  R Hoekstra; R A F M Chamuleau
Journal:  Int J Artif Organs       Date:  2002-03       Impact factor: 1.595

7.  Transformation of rat hepatocytes by transfection with simian virus 40 DNA to yield proliferating differentiated cells.

Authors:  C Woodworth; T Secott; H C Isom
Journal:  Cancer Res       Date:  1986-08       Impact factor: 12.701

8.  Definition of adenovirus type 5 functions involved in the induction of chromosomal aberrations in human cells.

Authors:  D Caporossi; S Bacchetti
Journal:  J Gen Virol       Date:  1990-04       Impact factor: 3.891

9.  Nuclear factor-kappaB mediates the inhibitory effects of tumor necrosis factor-alpha on growth hormone-inducible gene expression in liver.

Authors:  Mark D Buzzelli; Murali Nagarajan; John F Radtka; Margaret L Shumate; Maithili Navaratnarajah; Charles H Lang; Robert N Cooney
Journal:  Endocrinology       Date:  2008-08-21       Impact factor: 4.736

10.  Population expansion, clonal growth, and specific differentiation patterns in primary cultures of hepatocytes induced by HGF/SF, EGF and TGF alpha in a chemically defined (HGM) medium.

Authors:  G D Block; J Locker; W C Bowen; B E Petersen; S Katyal; S C Strom; T Riley; T A Howard; G K Michalopoulos
Journal:  J Cell Biol       Date:  1996-03       Impact factor: 10.539

View more
  32 in total

1.  Hepatocyte spheroids as an alternative to single cells for transplantation after ex vivo gene therapy in mice and pig models.

Authors:  Clara T Nicolas; Raymond D Hickey; Kari L Allen; Zeji Du; Rebekah M Guthman; Robert A Kaiser; Bruce Amiot; Aditya Bansal; Mukesh K Pandey; Lukkana Suksanpaisan; Timothy R DeGrado; Scott L Nyberg; Joseph B Lillegard
Journal:  Surgery       Date:  2018-06-06       Impact factor: 3.982

2.  Reversible transition between hepatocytes and liver progenitors for in vitro hepatocyte expansion.

Authors:  Han Wu; Xu Zhou; Gong-Bo Fu; Zhi-Ying He; Hong-Ping Wu; Pu You; Charles Ashton; Xin Wang; Hong-Yang Wang; He-Xin Yan
Journal:  Cell Res       Date:  2017-04-04       Impact factor: 25.617

Review 3.  A Pathway to Personalizing Therapy for Metastases Using Liver-on-a-Chip Platforms.

Authors:  A S Khazali; A M Clark; A Wells
Journal:  Stem Cell Rev Rep       Date:  2017-06       Impact factor: 5.739

4.  Biological and clinical insights offered by chemically induced liver progenitors (CLiPs).

Authors:  Takeshi Katsuda; Takahiro Ochiya
Journal:  Stem Cell Investig       Date:  2017-08-21

Review 5.  Techniques, challenges and future prospects for cell-based meat.

Authors:  Anmariya Benny; Kathiresan Pandi; Rituja Upadhyay
Journal:  Food Sci Biotechnol       Date:  2022-07-20       Impact factor: 3.231

6.  The need for non- or minimally-invasive biomonitoring strategies and the development of pharmacokinetic/pharmacodynamic models for quantification.

Authors:  Charles Timchalk; Thomas J Weber; Jordan N Smith
Journal:  Curr Opin Toxicol       Date:  2017-06

7.  Establishment and characterisation of a novel bovine SV40 large T-antigen-transduced foetal hepatocyte-derived cell line.

Authors:  Alexander Gleich; Bastian Kaiser; Julia Schumann; Herbert Fuhrmann
Journal:  In Vitro Cell Dev Biol Anim       Date:  2016-04-12       Impact factor: 2.416

8.  Non-invasive saliva human biomonitoring: development of an in vitro platform.

Authors:  Thomas J Weber; Jordan N Smith; Zana A Carver; Charles Timchalk
Journal:  J Expo Sci Environ Epidemiol       Date:  2015-11-11       Impact factor: 5.563

9.  Modeling of Hepatocytes Proliferation Isolated from Proximal and Distal Zones from Human Hepatocellular Carcinoma Lesion.

Authors:  Mauro Montalbano; Giuseppe Curcurù; Ali Shirafkan; Renza Vento; Cristiana Rastellini; Luca Cicalese
Journal:  PLoS One       Date:  2016-04-13       Impact factor: 3.240

10.  Genomic responses to hepatitis B virus (HBV) infection in primary human hepatocytes.

Authors:  Pierre-Benoit Ancey; Barbara Testoni; Marion Gruffaz; Marie-Pierre Cros; Geoffroy Durand; Florence Le Calvez-Kelm; David Durantel; Zdenko Herceg; Hector Hernandez-Vargas
Journal:  Oncotarget       Date:  2015-12-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.